Promedica International CME https://promedicacme.com Wed, 19 Sep 2018 21:04:03 +0000 en-US hourly 1 Treating Hyperlipidemic Patients with PCSK9 Agents https://promedicacme.com/blog-pcsk9/ https://promedicacme.com/blog-pcsk9/#respond Wed, 19 Sep 2018 21:01:43 +0000 https://promedicacme.com/?p=35184 Cardiovascular specialists have been excited about the clinical results coming in for many of our difficult to treat hyperlipidemic patients with the new PCSK9 agents.  We will delve into an important discussion on the “PCSK9 Revolution” at the annual Cardiovascular Disease Management: A Case-Based Approach, 6th Annual Symposium, which will take place October 11-12, 2018 […]

The post Treating Hyperlipidemic Patients with PCSK9 Agents appeared first on Promedica International CME.

]]>
Cardiovascular specialists have been excited about the clinical results coming in for many of our difficult to treat hyperlipidemic patients with the new PCSK9 agents.  We will delve into an important discussion on the “PCSK9 Revolution” at the annual Cardiovascular Disease Management: A Case-Based Approach, 6th Annual Symposium, which will take place October 11-12, 2018 at the Arizona Biltmore in Phoenix, AZ.  Christie Ballantyne, an international lipid expert, will be joining us from the Baylor College of Medicine in Houston, Texas, to talk about these exciting agents and to present new data on anti-inflammatory agents in patients with cardiovascular disease.

More information and registration for the symposium can be found online!

I welcome your thoughts on the subject in the discussion below, and hope to see you in Phoenix this October!

Sincerely,
Richard R. Heuser, MD, FACC
Chief of Cardiology
St. Luke’s Medical Center
Professor of Medicine
University of Arizona College of Medicine
Phoenix, AZ

The post Treating Hyperlipidemic Patients with PCSK9 Agents appeared first on Promedica International CME.

]]>
https://promedicacme.com/blog-pcsk9/feed/ 0
Are We Doing Enough to Treat Hypertension? https://promedicacme.com/cdm18-blog-hypertension/ https://promedicacme.com/cdm18-blog-hypertension/#respond Fri, 24 Aug 2018 18:44:46 +0000 https://promedicacme.com/?p=34941 Hypertension rates have been steadily growing for decades.  Our health care system is now also facing an epidemic of CHF brought about by a number of factors, including untreated hypertension. As cardiologists, we see a critical opportunity aimed at addressing the disease before it takes hold and finding better ways to detect, treat and manage […]

The post Are We Doing Enough to Treat Hypertension? appeared first on Promedica International CME.

]]>
Hypertension rates have been steadily growing for decades.  Our health care system is now also facing an epidemic of CHF brought about by a number of factors, including untreated hypertension. As cardiologists, we see a critical opportunity aimed at addressing the disease before it takes hold and finding better ways to detect, treat and manage high blood pressure.

As a first-line of defense, regular physical activity, a healthy diet and managing stress are key factors.  However, when lifestyle changes alone cannot reduce hypertension, medication, including diuretics, beta-blockers and various prescription inhibitors become treatment options. The choice of medication depends on a variety of factors, including other conditions patients may be battling.

We will delve into these important discussions at the annual Cardiovascular Disease Management: A Case-Based Approach, 6th Annual Symposium, which will take place October 11-12, 2018 at the Arizona Biltmore in Phoenix, AZ.  The scientific program will feature important conversations on the updated hypertension guidelines and their implications for patient management and treatment. We tackle cardiovascular disease through a case-based approach to allow the entire cardiovascular care team to examine clinical results in the field, and discuss trends, critical breakthroughs, and new options on the horizon.

We will be joined by Dr. Michael Weber, one of the world’s foremost experts on hypertension, to discuss the implications of the new guidelines now that nearly 50% of Americans have hypertension.  Dr. J. Brian Byrd will also join us to speak about treatable causes of hypertension and whether or not we are recognizing them all.  Also, Dr. Nancy Sweitzer will share details about new agents and treatment options for CHF, an important piece of the puzzle.  More information on the symposium can be found on our website.

I welcome your thoughts on the subject in the discussion below, and hope to see you in Phoenix this October!

Sincerely,
Richard R. Heuser, MD, FACC
Chief of Cardiology
St. Luke’s Medical Center
Professor of Medicine
University of Arizona College of Medicine
Phoenix, AZ

The post Are We Doing Enough to Treat Hypertension? appeared first on Promedica International CME.

]]>
https://promedicacme.com/cdm18-blog-hypertension/feed/ 0
New Treatments for CHF https://promedicacme.com/new-treatments-chf/ https://promedicacme.com/new-treatments-chf/#respond Mon, 25 Jul 2016 21:28:56 +0000 https://promedicacme.com/?p=25550 Case Study: Your 80 year old patient with CHF is already on an ACE inhibitor, appropriate beta blocker, and a spironolactone inhibitor.  He has a synchronized pacemaker and an ICD but still comes to the hospital with worsening symptoms every few months.  How would you treat this patient? We will discuss new treatment agents for […]

The post New Treatments for CHF appeared first on Promedica International CME.

]]>
Case Study:

Your 80 year old patient with CHF is already on an ACE inhibitor, appropriate beta blocker, and a spironolactone inhibitor.  He has a synchronized pacemaker and an ICD but still comes to the hospital with worsening symptoms every few months.  How would you treat this patient?

We will discuss new treatment agents for CHF at the Cardiovascular Disease Management: A Case-Based Approach, 4th Annnual Symposium, taking place October 13 – 14, 2016 at the Arizona Biltmore in Phoenix, AZ.  View the program and register for the symposium today!

The post New Treatments for CHF appeared first on Promedica International CME.

]]>
https://promedicacme.com/new-treatments-chf/feed/ 0
Lipid experts discuss PCSK9 Inhibitors at CDM 2015 https://promedicacme.com/lipid-experts-discuss-pcsk9-inhibitors-at-cdm-2015/ https://promedicacme.com/lipid-experts-discuss-pcsk9-inhibitors-at-cdm-2015/#comments Thu, 06 Aug 2015 21:20:02 +0000 http://blog.promedicacme.com/?p=93 Dr. Heuser is interested to hear what your approach would be with the following patient. Please comment below with your thoughts. You see a 50 year old gentleman with 3 vessel coronary disease. This non-diabetic, non-smoker really takes care of himself, but in spite of great effort cannot tolerate any statin. Even at normal weight, […]

The post Lipid experts discuss PCSK9 Inhibitors at CDM 2015 appeared first on Promedica International CME.

]]>
Dr. Heuser is interested to hear what your approach would be with the following patient. Please comment below with your thoughts.

You see a 50 year old gentleman with 3 vessel coronary disease. This non-diabetic, non-smoker really takes care of himself, but in spite of great effort cannot tolerate any statin. Even at normal weight, his LDL still is persistently over 150. His 30%-40% lesions are not severe enough for PCI or surgery, however 10 years ago, you stented his LAD lesion which continues to be patent. His FFR is non-significant in any of these lesions, but more importantly, what can you give him to reduce his risk for cardiovascular disease progression?

Come to the Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium and find out from the world’s leading lipid experts on how and when you will use the PCSK9 inhibitor. The scientific sessions will take place October 1-2, 2015 at the Arizona Biltmore Hotel.

The post Lipid experts discuss PCSK9 Inhibitors at CDM 2015 appeared first on Promedica International CME.

]]>
https://promedicacme.com/lipid-experts-discuss-pcsk9-inhibitors-at-cdm-2015/feed/ 1
Discussion on PCSK9 Inhibitors https://promedicacme.com/discussion-on-pcsk9-inhibitors/ https://promedicacme.com/discussion-on-pcsk9-inhibitors/#respond Thu, 18 Jun 2015 20:54:41 +0000 http://blog.promedicacme.com/?p=89 A 65 year old asymptomatic woman sees you for therapy. She has a positive family history of early CV mortality. Her cholesterol is over 400 with intolerance to statins. She carries a diagnosis of homozygous familial hypercholesterolemia (HoFH). What is the role of the new PCSK9 inhibitors in treating patients like the one described above? […]

The post Discussion on PCSK9 Inhibitors appeared first on Promedica International CME.

]]>
A 65 year old asymptomatic woman sees you for therapy. She has a positive family history of early CV mortality. Her cholesterol is over 400 with intolerance to statins. She carries a diagnosis of homozygous familial hypercholesterolemia (HoFH). What is the role of the new PCSK9 inhibitors in treating patients like the one described above?

Dr. Heuser is interested to hear what your approach would be with this patient. Please comment below with your thoughts.

We hope to see you at the upcoming Cardiovascular Disease Management symposium, taking place October 1-2, 2015. For the detailed program, registration, CME, and hotel information, please visit: http://promedicacme.com/meeting/Cardiovascular-Disease-Management-A-Case-Based-110.html.

The post Discussion on PCSK9 Inhibitors appeared first on Promedica International CME.

]]>
https://promedicacme.com/discussion-on-pcsk9-inhibitors/feed/ 0
Case Study: Women & Heart Disease https://promedicacme.com/case-study-women-heart-disease/ https://promedicacme.com/case-study-women-heart-disease/#comments Tue, 26 May 2015 15:55:49 +0000 http://blog.promedicacme.com/?p=84 The following case study will be referenced at the upcoming Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium, which will take place October 1-2, 2015 at the historic Arizona Biltmore Hotel in Phoenix, Arizona. Dr. Heuser is interested in your approach. Let us know how you would treat the patient in the comments below. […]

The post Case Study: Women & Heart Disease appeared first on Promedica International CME.

]]>
The following case study will be referenced at the upcoming Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium, which will take place October 1-2, 2015 at the historic Arizona Biltmore Hotel in Phoenix, Arizona.

Dr. Heuser is interested in your approach. Let us know how you would treat the patient in the comments below.

A 32-year-old woman comes in with recurrent visits to the emergency room for chest pain. The pain is substernal but is sometimes associated with nausea and belly pain. She denies any diaphoresis or dyspnea. Her risk factors for coronary disease include: Family history of early sudden death in a brother in his 40s. Her physical examination reveals her blood pressure to be 100/70, her pulse is 70 and regular. The rest of her physical examination is normal. Her BMI is normal and her labs are completely normal. How would you evaluate and manage this patient?

For the detailed program, registration, CME, and hotel information for CDM 2015, please visit: http://promedicacme.com/meeting/Cardiovascular-Disease-Management-A-Case-Based-110.html.

The post Case Study: Women & Heart Disease appeared first on Promedica International CME.

]]>
https://promedicacme.com/case-study-women-heart-disease/feed/ 2
Case Study: Aortic Valve Disease https://promedicacme.com/case-study-aortic-valve-disease/ https://promedicacme.com/case-study-aortic-valve-disease/#comments Fri, 15 May 2015 17:01:42 +0000 http://blog.promedicacme.com/?p=81 Dr. Rich Heuser’s upcoming Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium, will take place October 1-2, 2015 at the historic Arizona Biltmore Hotel in Phoenix, Arizona. The following case study will be used for the discussion on Aortic Valve Disease. In the comments below, let Dr. Heuser know how you would manage this […]

The post Case Study: Aortic Valve Disease appeared first on Promedica International CME.

]]>
Dr. Rich Heuser’s upcoming Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium, will take place October 1-2, 2015 at the historic Arizona Biltmore Hotel in Phoenix, Arizona. The following case study will be used for the discussion on Aortic Valve Disease.

In the comments below, let Dr. Heuser know how you would manage this patient:

An 60-year-old healthy male comes to see you with symptomatic aortic stenosis. He has had episodes of congestive heart failure requiring hospitalizations two times over the last month. He has been known to have aortic stenosis by catheterization 3 years ago, with an aortic gradient of 30mm. Now a recent heart catheterization shows an aortic gradient of 60mm gradient and the aortic valve area calculated at 0.8. His coronaries by arteriography are normal. He has no aortic insufficiency. He has no other risk factors or comorbidities. He would prefer not have have a surgical procedure.

For the detailed program, registration, CME, and hotel information for CDM 2015, please visit: http://promedicacme.com/meeting/Cardiovascular-Disease-Management-A-Case-Based-110.html.

The post Case Study: Aortic Valve Disease appeared first on Promedica International CME.

]]>
https://promedicacme.com/case-study-aortic-valve-disease/feed/ 3
Use of the Prodigy Balloon for CTO – “Vascular Disease Management” https://promedicacme.com/use-of-the-prodigy-balloon-for-cto-vascular-disease-management/ https://promedicacme.com/use-of-the-prodigy-balloon-for-cto-vascular-disease-management/#respond Thu, 19 Jun 2014 19:17:03 +0000 http://blog.promedicacme.com/?p=69 Drs. Soundos K. Moualla, and Richard R. Heuser have recently co-authored an important article on the Vascular Disease Management website. We encourage you to read “The Utility of the Prodigy Balloon in Chronic Total Occlusion”. Dr. Heuser is the program director of the upcoming “Cardiovascular Disease Management: A Case-Based Approach” symposium, taking place October 10-11, […]

The post Use of the Prodigy Balloon for CTO – “Vascular Disease Management” appeared first on Promedica International CME.

]]>
Drs. Soundos K. Moualla, and Richard R. Heuser have recently co-authored an important article on the Vascular Disease Management website. We encourage you to read “The Utility of the Prodigy Balloon in Chronic Total Occlusion”.

Dr. Heuser is the program director of the upcoming “Cardiovascular Disease Management: A Case-Based Approach” symposium, taking place October 10-11, 2014 in Phoenix. This year, the program will continue to focus on the questions physicians and the cardiovascular care team face in a daily clinical setting. Case examples will be used to illustrate new guidelines and provide practical approaches to excellent patient care.

Register for the symposium.
View the scientific program.

The post Use of the Prodigy Balloon for CTO – “Vascular Disease Management” appeared first on Promedica International CME.

]]>
https://promedicacme.com/use-of-the-prodigy-balloon-for-cto-vascular-disease-management/feed/ 0
Retrograde Crossing Post on “Vascular Disease Management” https://promedicacme.com/retrograde-crossing-post-on-vascular-disease-management/ https://promedicacme.com/retrograde-crossing-post-on-vascular-disease-management/#respond Mon, 22 Jul 2013 19:00:48 +0000 http://blog.promedicacme.com/?p=55 Dr. Richard R. Heuser, program director for the upcoming Cardiovascular Disease Management: A Case-Based Approach symposium taking place October 4-5, 2013, has recently posted a must-read article on Vascular Disease Management co-authored by Dr. Ajay Mhatre. To read the article, click here: Retrograde Crossing: When the Front Door is Locked, Part 2 To register for […]

The post Retrograde Crossing Post on “Vascular Disease Management” appeared first on Promedica International CME.

]]>
Dr. Richard R. Heuser, program director for the upcoming Cardiovascular Disease Management: A Case-Based Approach symposium taking place October 4-5, 2013, has recently posted a must-read article on Vascular Disease Management co-authored by Dr. Ajay Mhatre.

To read the article, click here: Retrograde Crossing: When the Front Door is Locked, Part 2

To register for the Cardiovascular Disease Management symposium, click here: http://www.promedicacme.com/meeting/Cardiovascular-Disease-Management-A-Case-92.html.

The post Retrograde Crossing Post on “Vascular Disease Management” appeared first on Promedica International CME.

]]>
https://promedicacme.com/retrograde-crossing-post-on-vascular-disease-management/feed/ 0
UTHealth/Memorial Hermann first to implant new aortic valve in Houston https://promedicacme.com/uthealthmemorial-hermann-first-to-implant-new-aortic-valve-in-houston/ https://promedicacme.com/uthealthmemorial-hermann-first-to-implant-new-aortic-valve-in-houston/#respond Thu, 17 Nov 2011 19:00:01 +0000 http://blog.promedicacme.com/2011/11/17/uthealthmemorial-hermann-first-to-implant-new-aortic-valve-in-houston/ Houston Aortic Symposium program director Dr. Hazim J. Safi, and faculty member Anthony L. Estrera are part of the team that will implant the first Sapien heart valve after it’s recent FDA approval this month! Join Drs. Safi and David D. McPherson in Houston March 22, 23 & 24 , 2012 to discuss this and […]

The post UTHealth/Memorial Hermann first to implant new aortic valve in Houston appeared first on Promedica International CME.

]]>
Houston Aortic Symposium program director Dr. Hazim J. Safi, and faculty member Anthony L. Estrera are part of the team that will implant the first Sapien heart valve after it’s recent FDA approval this month!

Join Drs. Safi and David D. McPherson in Houston March 22, 23 & 24 , 2012 to discuss this and other timely developments in the diagnosis and treatment of aortic disease.  To download the scientific program, follow this link and click “view”.

Read the full article here:

UTHealth/Memorial Hermann first to implant new aortic valve in Houston.

The post UTHealth/Memorial Hermann first to implant new aortic valve in Houston appeared first on Promedica International CME.

]]>
https://promedicacme.com/uthealthmemorial-hermann-first-to-implant-new-aortic-valve-in-houston/feed/ 0